Fertility Test Market - Major Revenue Surge is Expected by 2025


Posted July 6, 2022 by vmack2187

The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.
 
Market Estimation Methodology:

A detailed market estimation approach was followed to estimate and validate the size of the global fertility test market and other dependent submarkets.

# The key players in the global fertility test market were identified through secondary research, and their global market shares were determined through primary and secondary research.

# The research methodology includes the study of the annual and quarterly financial reports of the top market players as well as interviews with industry experts for key insights on the global fertility test market.

# All percentage shares, splits, and breakdowns were determined by using secondary sources and verified through primary sources.

# All the possible parameters that affect the market segments covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Major Growth Influencing Factors:

Growth in this market is primarily driven by by the increasing first-time pregnancy age in women, declining fertility rate among men and women, growing number of women suffering from disorders such as PCOS, emergence of advanced ovulation monitors, and the increased awareness of fertility testing in both developed as well as developing countries.

Projected Surge in Revenue Generation:

The fertility test market is projected to reach USD 680 Million by 2025 from USD 472 Million in 2020, at a CAGR of 7.5 % the forecast period.

Downlaod PDF [email protected]
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139945432

Data Triangulation:

After deriving the overall fertility test market value data from the market size estimation process, the total market value data was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all the segments, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by studying various qualitative and quantitative variables as well as by analyzing regional trends for both the demand- and supply-side macroindicators.

Restraint: Lesser precision of ovulation prediction kits

Ovulation prediction kits measure the luteinizing hormone (LH) surge that precedes about 24–36 hours prior to ovulation. These kits, however, cannot accurately confirm ovulation. In conditions such as luteinized unruptured follicle syndrome (in which a woman’s egg fails to emerge from its follicle after the LH surge occurs), ovulation predictors fail to give accurate results. Also, urinary LH measurement is only predictive of the onset of ovulation and cannot determine the date of ovulation or anovulation, thereby only indicating a very small period (of only about two days) of the fertile window.

Ovulation monitors can only test LH and do not identify other important ovulation signs, such as whether the cervical mucus is conductive for fertilization. Also, these monitors do not work when certain fertility drugs, such as Pergonal or the hormone hCG (Human Chorionic Gonadotropin), are present in the urine. Another major drawback of these kits is that they do not function for women in their 40s (specifically those approaching menopause) as they have increased levels of LH. These disadvantages of ovulation monitors limit their predictive capabilities and thus are restricting their adoption among end users.

Challenge: High cost of fertility testing monitors

Price and brand recognition are two important criteria for the adoption of fertility testing kits and monitors across the globe. Being elective and non-reimbursable in nature, the price of a device is a prime determinant for its use. Although advanced branded fertility monitors possess high accuracy in identifying the fertility window, they are priced at a premium due to the high costs involved in maintaining brand loyalty, obtaining regulatory approvals, and incorporating the software in the systems.

Opportunity: Emerging nations to offer new growth avenues

Emerging markets such as China, India, Brazil, and Mexico are expected to offer significant growth opportunities to players operating in the fertility test market. The demand for fertility and ovulation monitors in emerging countries is expected to grow significantly in the coming years due to the rising infertility rates, increasing prevalence of PCOS and obesity, growing fertility education, and easy availability of fertility monitors through e-commerce websites, pharmacies, and retail shops/drugstores. In addition, friendly regulatory policies and less competition among players in developing markets (as compared to developed markets) have encouraged companies to focus on emerging countries.

Recent Developments in the Global Fertility Test Market:

# February 2021, Fertility Focus partnered with ExSeed Health, a home-based sperm testing company. Under this partnership, both companies would together provide solutions to couples planning a pregnancy.

# May 2019, Fertility Focus (UK) launched an updated version of OvuSense App— OvuSense App v.2—with features such as increased flexibility in data viewing (three different ways), more choices for logging events than most of the apps, and increased accuracy in terms of monitoring cycles.

# January 2017, NFI Consumer Healthcare (US), a division of Gregory Pharmaceutical Holdings (US), completed the acquisition of the e.p.t OTC pregnancy.

Request Sample [email protected]
https://www.marketsandmarkets.com/requestsampleNew.asp?id=139945432

End Users:

The home care settings segment is expected to register the highest CAGR during the forecast period

Based on end-users, the fertility test market has been segmented based on end-user category—home care settings, hospitals and fertility clinics, and other end users. The large share and high growth of this segment can be attributed to the inclination of patients toward self-monitoring of healthcare conditions, easy access to fertility and ovulation monitors on e-commerce websites, availability of user-friendly and easy-to-handle devices, and the growing preference for the confidentiality of test results.

Geographical Growth Dynamics:

North America dominated the global fertilty test market in 2020

North America, comprising the US and Canada, accounted for the largest share of the fertility test market in 2020. The large share of this region can primarily be attributed to factors such as high prevalence of infertility, increasing awareness about fertility testing among women, the rising age of first-time pregnancies in women, and the easy availability of ovulation and fertility monitors through e-commerce websites.
-- END ---
Contact Email [email protected]
Issued By Makarand Vaidya
Country United States
Categories Industry , Medical , News
Tags fertility test , fertility test market
Last Updated July 6, 2022